128 Channel Photodiode Array Can Be Used for Medical X-Rays, Product Testing and Food Inspection

Fremont, CA -- March 31, 2003 -- PerkinElmer Optoelectronics, a global technology leader providing market-driven integrated solutions for biomedical and industrial applications, today announced the introduction of a new photodiode array that converts x-rays into visible light to produce high-quality, accurate images - without affecting the integrity of the object being viewed.

Leveraging its 20 year history using photodiodes on various substrates and working with scintillator crystals, PerkinElmer's 128 channel photodiode array creates unparalleled images in x-ray applications to improve quality, safety, speed and cost-effectiveness of testing processes for a variety of industries.

Traditionally used by airports for fast and accurate luggage scanning, PerkinElmer's advanced imaging technology is now available for use in other x-ray applications that require non-destructive testing (NDT) of materials. Applications include manufacturing process control, archaeology, product testing and food inspection, in which the inner workings of complex objects can be analyzed or defects detected quickly and reliably without modification of the item being inspected. From x-rays of teeth and bones to the inspection of automobile parts and contained goods, this testing method saves time and money by ensuring quality, non-destructive results.

PerkinElmer provides a large variety of photodiode arrays in custom designed solutions to meet the needs of instrument OEMs and designers looking to create a competitive advantage through best-in-class engineering and manufacturing practices.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) fluctuations in the global economic and political environments; (4) markets into which we sell our products decline or do not grow as anticipated; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) our ability to produce an adequate quantity of products to meet our customers' demands; (12) the manufacture and sale of products may expose us to product liability claims; (13) our failure to maintain compliance with applicable government regulations; (14) regulatory changes; (15) our failure to comply with health care industry regulations; (16) economic, political and other risks associated with foreign operations; (17) our ability to retain key personnel; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; and (21) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

		For Further Information:
		Media Contact: Kristen Kmetetz Porter Novelli Life Sciences 617.897.8272 (office) Kristen.kmetetz@porternovelli.com or Francine S. Bernitz Marketing Director, Illumination and Detection Solutions PerkinElmer, Inc. Francine.bernitz@perkinelmer.com 978.224.4321 (office) 781.789.3178 (cell)